Prognostic significance of ARL9 and its methylation in low-grade glioma.
Estimating gene expression from DNA methylation and copy number variation: A deep
Minimum error calibration and normalization for genomic copy number analysis.
Development and validation of a six-RNA binding proteins prognostic signature and candidate drugs for prostate cancer
Development and validation of a 14-gene signature for prognosis prediction in hepatocellular carcinoma
Identification and validation of a six-lncRNA prognostic signature with its ceRNA networks and candidate drugs in lower-grade gliomas
Exploration of a novel prognostic risk signatures and immune checkpoint molecules in endometrial carcinoma microenvironment
Analysis of relapse-associated alternative mRNA splicing and construction of a prognostic signature predicting relapse in I-III colon cancer
Identification of angiotensin-converting enzyme 2 (ACE2) protein as the potential biomarker in SARS-CoV-2 infection-related lung cancer using computational analysis
Clinical and genomic characterization of neutral tumor evolution in Head and Neck Squamous Cell Carcinoma
CancerEnD: A database of cancer associated enhancers.
Construction and validation of a TP53-associated immune prognostic model for gastric cancer
A pan-cancer analysis of the oncogenic role of staphylococcal nuclease domain-containing protein 1 (SND1) in human tumors
Identifying potential DNA methylation markers in early-stage colorectal Cancer.
A novel prognostic index of hepatocellular carcinoma based on immunogenomic landscape analysis
The chromosome 19 microRNA cluster, regulated by promoter hypomethylation, is associated with tumour burden and poor prognosis in patients with hepatocellular carcinoma
DNA methylation data-based prognosis-subtype distinctions in patients with esophageal carcinoma by bioinformatic studies
A 16-mRNA signature optimizes recurrence-free survival prediction of Stages II and III gastric cancer
The prognostic value and potential subtypes of immune activity scores in three major urological cancers
Identification of novel genes in testicular cancer microenvironment based on ESTIMATE algorithm-derived immune scores
Comprehensive landscape of STEAP family functions and prognostic prediction value in glioblastoma
Development and validation of a CpG island methylator phenotype-related prognostic signature for cholangiocarcinoma
PSMC6 promotes osteoblast apoptosis through inhibiting PI3K/AKT signaling pathway activation in ovariectomy-induced osteoporosis mouse model
Bioinformatic identification of key pathways, hub genes, and microbiota for therapeutic intervention in Helicobacter pylori infection
Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels tumour heterogeneity plus M2-like tumour-associated macrophage infiltration and aggressiveness in TNBC
Tumor immune microenvironment in cancer patients with leukocytosis.
Tumor-infiltrating CD39 + CD8 + T cells determine poor prognosis and immune evasion in clear cell renal cell carcinoma patients
Tumour microenvironment (TME) characterization identified prognosis and immunotherapy response in muscle-invasive bladder cancer (MIBC)
ZFHX3 mutation as a protective biomarker for immune checkpoint blockade in non-small cell lung cancer
Immune checkpoint-related serum proteins and genetic variants predict outcomes of localized prostate cancer, a cohort study
Anti-angiogenesis therapy overcomes the innate resistance to PD-1/PD-L1 blockade in VEGFA-overexpressed mouse tumor models
Lauren classification identifies distinct prognostic value and functional status of intratumoral CD8 + T cells in gastric cancer
Comprehensive landscape of immune-checkpoints uncovered in clear cell renal cell carcinoma reveals new and emerging therapeutic targets
Identification and validation of tumor environment phenotypes in lung adenocarcinoma by integrative genome-scale analysis